ALNY
ALNY
NASDAQ · Biotechnology

Alnylam Pharmaceuticals Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$328.16
-3.08 (-0.93%)
As of Feb 8, 3:10 PM ET ·
Analyst Consensus
Strong Buy
36
Analysts
Very High
Coverage
Buy 27 75%
Hold 9 25%
Sell 0 0%
Price Target
Analyst Price Target -68.8% upside
Low Target $75.08
Average Target $102.31
High Target $108.98
Current Price $328.16
Current
$328.16
Target
$102.31
$75.08 $102.31 avg $108.98
Scenario Analysis
Bear Case
$75.08
-77.1%
Low target
Base Case
$102.31
-68.8%
Avg target
Bull Case
$108.98
+-66.8%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$495.55
-33.8% from high
52-Week Low
$205.87
+59.4% from low
50-Day SMA
$392.55
-16.4% vs SMA
200-Day SMA
$385.51
-14.9% vs SMA
RSI (14)
33.6
Neutral
Target vs 52W High
$102.31
-79.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%